Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16092| Title: | Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No | Austin Authors: | Krishnananthan, Nishanth;Lawrentschuk, Nathan | Affiliation: | Austin Health, Heidelberg, Victoria, Australia University of Melbourne, Department of Surgery, Austin Health, Melbourne, Australia Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Jun-2016 | Publication information: | International Brazilian Journal Of Urology 2016 May-June; 42(3): 418-421 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16092 | DOI: | 10.1590/S1677-5538.IBJU.2016.03.04 | ORCID: | 0000-0001-8553-5618 | Journal: | International Brazilian Journal Of Urology | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/27286102 | Type: | Journal Article | Subjects: | Prostatic Neoplasms Prostate cancer Disease Therapeutics Watchful waiting |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.